U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.731del (p.Gly244fs) AND Rett syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Mar 22, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000133203.4

Allele description [Variation Report for NM_001110792.2(MECP2):c.731del (p.Gly244fs)]

NM_001110792.2(MECP2):c.731del (p.Gly244fs)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.731del (p.Gly244fs)
Other names:
NM_001110792.2(MECP2):c.731del; p.Gly244fs
HGVS:
  • NC_000023.11:g.154031137del
  • NG_007107.3:g.110971del
  • NM_001110792.2:c.731delMANE SELECT
  • NM_001316337.2:c.416del
  • NM_001369391.2:c.416del
  • NM_001369392.2:c.416del
  • NM_001369393.2:c.416del
  • NM_001369394.2:c.416del
  • NM_001386137.1:c.26del
  • NM_001386138.1:c.26del
  • NM_001386139.1:c.26del
  • NM_004992.3:c.695del
  • NM_004992.4:c.695del
  • NP_001104262.1:p.Gly244fs
  • NP_001303266.1:p.Gly139fs
  • NP_001356320.1:p.Gly139fs
  • NP_001356321.1:p.Gly139fs
  • NP_001356322.1:p.Gly139fs
  • NP_001356323.1:p.Gly139fs
  • NP_001373066.1:p.Gly9fs
  • NP_001373067.1:p.Gly9fs
  • NP_001373068.1:p.Gly9fs
  • NP_004983.1:p.Gly232fs
  • LRG_764t1:c.731del
  • LRG_764t2:c.695del
  • AJ132917.1:c.695delG
  • LRG_764:g.110971del
  • LRG_764p1:p.Gly244fs
  • LRG_764p2:p.Gly232fs
  • NC_000023.10:g.153296584del
  • NC_000023.10:g.153296588del
  • NG_007107.2:g.110995del
  • NM_004992.3:c.695delG
Protein change:
G139fs
Links:
dbSNP: rs63260260
NCBI 1000 Genomes Browser:
rs63260260
Molecular consequence:
  • NM_001110792.2:c.731del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001316337.2:c.416del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369391.2:c.416del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369392.2:c.416del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369393.2:c.416del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369394.2:c.416del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386137.1:c.26del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386138.1:c.26del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386139.1:c.26del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_004992.4:c.695del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Rett syndrome (RTT)
Synonyms:
Autism, dementia, ataxia, and loss of purposeful hand use; Rett's disorder
Identifiers:
MONDO: MONDO:0010726; MedGen: C0035372; Orphanet: 3095; Orphanet: 778; OMIM: 312750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000188201RettBASE
no assertion criteria provided
Pathogenic
(Feb 18, 2008)
de novo, unknowncuration

PubMed (4)
[See all records that cite these PMIDs]

SCV004808882Centre for Population Genomics, CPG
criteria provided, single submitter

(McKnight et al. (Hum Mutat. 2022))
Pathogenic
(Mar 22, 2024)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration
not providedunknownyes3not providednot provided3Nocuration
not providedde novoyes2not providednot provided2Nocuration

Citations

PubMed

Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome.

Obata K, Matsuishi T, Yamashita Y, Fukuda T, Kuwajima K, Horiuchi I, Nagamitsu S, Iwanaga R, Kimura A, Omori I, Endo S, Mori K, Kondo I.

J Med Genet. 2000 Aug;37(8):608-10. No abstract available.

PubMed [citation]
PMID:
10991688
PMCID:
PMC1734655

Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech.

Yamashita Y, Kondo I, Fukuda T, Morishima R, Kusaga A, Iwanaga R, Matsuishi T.

Brain Dev. 2001 Dec;23 Suppl 1:S157-60.

PubMed [citation]
PMID:
11738864
See all PubMed Citations (5)

Details of each submission

From RettBASE, SCV000188201.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providedNocuration PubMed (4)
2not provided1not providednot providedcuration PubMed (4)
3not provided1not providedNocuration PubMed (4)
4not provided1not providedNocuration PubMed (4)
5not provided1not providedNocuration PubMed (4)

Description

Rett syndrome - Classical

"Rett syndrome - Classical"
"Rett syndrome - atypical"
"Rett syndrome - classical"
"Rett syndrome - classical"
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyes1not providednot provided1not providednot providednot provided
2unknownyes1Blood or skinnot provided1not providednot providednot provided
3unknownyes1Bloodnot provided1not providednot providednot provided
4de novoyes1bloodnot provided1not providednot providednot provided
5unknownyes1bloodnot provided1not providednot providednot provided

From Centre for Population Genomics, CPG, SCV004808882.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). Has been observed in at least 5 individuals with phenotypes consistent with MECP2-related disease (PS4). PubMed: PMID:10508514 ,10991688‚Äö 11738864‚Äö 15057977‚Äö 15737703, ClinVar Variation ID: 143662 This variant is absent from gnomAD (PM2_Supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024